share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Director SMITH JAMES C

Pfizer | 4: Statement of changes in beneficial ownership of securities-Director SMITH JAMES C

辉瑞 | 4：持股变动声明-董事 SMITH JAMES C
美股sec公告 ·  04/26 13:28
Moomoo AI 已提取核心信息
James C. Smith, a reporting person for Pfizer Inc. [PFE], has been involved in a transaction with the company's stock. The action took place on April 25, 2024. However, the details regarding the nature of the transaction, such as the number of shares traded, the transaction price, and the resulting shareholding, have not been disclosed. Investors are advised to await further information for a complete understanding of the impact of this event on their investment decisions.
James C. Smith, a reporting person for Pfizer Inc. [PFE], has been involved in a transaction with the company's stock. The action took place on April 25, 2024. However, the details regarding the nature of the transaction, such as the number of shares traded, the transaction price, and the resulting shareholding, have not been disclosed. Investors are advised to await further information for a complete understanding of the impact of this event on their investment decisions.
辉瑞公司 [PFE] 的举报人詹姆斯·史密斯参与了该公司股票的交易。该行动于2024年4月25日举行。但是，有关交易性质的细节，例如交易的股票数量、交易价格以及由此产生的股权，尚未披露。建议投资者等待进一步的信息，以全面了解这一事件对其投资决策的影响。
辉瑞公司 [PFE] 的举报人詹姆斯·史密斯参与了该公司股票的交易。该行动于2024年4月25日举行。但是，有关交易性质的细节，例如交易的股票数量、交易价格以及由此产生的股权，尚未披露。建议投资者等待进一步的信息，以全面了解这一事件对其投资决策的影响。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息